Lew Cantley (Cornell)

Scoop: Famed can­cer re­searcher — and biotech founder — Lew Cant­ley is head­ed to Dana-Far­ber

Lew Cant­ley, the famed can­cer re­searcher best known for his dis­cov­ery of the PI3K path­way and his ground­break­ing work on can­cer me­tab­o­lism, is head­ed to Dana-Far­ber.

We got tipped off by some­one at the in­sti­tute that Cant­ley will make his move from Weill Cor­nell Med­i­cine next Feb­ru­ary af­ter Dana-Far­ber chief Lau­rie Glim­ch­er sent out a note herald­ing his im­pend­ing ar­rival as a fac­ul­ty mem­ber in the De­part­ment of Can­cer Bi­ol­o­gy. That puts the ex-Har­vard pro­fes­sor right back in the cen­ter of things dur­ing an un­prece­dent­ed biotech boom that has put Cam­bridge/Boston right at the epi­cen­ter of drug R&D.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.